Sanofi has become the latest big pharma company to boost manufacturing in the US with a hefty investment as the biopharma industry safeguards itself against the continued threat of pharma tariffs from ...

FRAMINGHAM — Sanofi Genzyme is doubling ... With some 5,000 workers in Massachusetts, Sanofi Genzyme continues to be the state’s largest employer in the life sciences industry.

in Framingham will keep the company in the city while Sanofi builds a 900,000-square-foot complex in Cambridge to consolidate much of its Massachusetts operations. That facility is expected to ...

Drugmaker Sanofi will keep its presence in Framingham while it consolidates its Massachusetts operations at a new 900,000 square-foot lease in Cambridge. The Cambridge offices are expected to open ...

Despite receiving a prior wrist slap from the FDA in the shape of a Form 483, Sanofi is still working to right the ship at a U.S. drug ingredients plant tied to its longstanding subsidiary Genzyme.

Global healthcare company Sanofi, headquartered in Paris, France, is announcing another pricey purchase in the U.S.

The U.S. Food and Drug Administration has warned the pharmaceutical company Sanofi about significant ... their Genzyme manufacturing plant in Framingham, Massachusetts. On Jan. 15, 2025, a warning ...

The Food and Drug Administration approved the Framingham, Massachusetts, facility for the production of Fabrazyme, a treatment for Fabry disease, Paris-based Sanofi said today in a statement.

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter ...